IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition
The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metasta...
Saved in:
Published in | Oncology letters Vol. 13; no. 6; pp. 4657 - 4660 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Greece
Spandidos Publications UK Ltd
01.06.2017
D.A. Spandidos |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer. |
---|---|
AbstractList | The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer. The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer.The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer. |
Author | Shang, Guan-Sheng Liu, Lunxu Qin, Yi-Wei |
AuthorAffiliation | 2 Department of Intensive Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China 1 Department of Thoracic Surgery, West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China |
AuthorAffiliation_xml | – name: 2 Department of Intensive Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China – name: 1 Department of Thoracic Surgery, West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China |
Author_xml | – sequence: 1 givenname: Guan-Sheng surname: Shang fullname: Shang, Guan-Sheng – sequence: 2 givenname: Lunxu surname: Liu fullname: Liu, Lunxu – sequence: 3 givenname: Yi-Wei surname: Qin fullname: Qin, Yi-Wei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28599466$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc9KHTEUxkNRqrXuui4BN110rkluJplsBJHaChfd6DpkMme8kUxym8wI97F8kT5TM_gHFUMgh-R3Pr585wvaCTEAQt8oWSwbxY6jXzBC5UIQ3nxC-1QqVlHSsJ2XWvI9dJjzHSmrFrRpxGe0x5paKS7EPtIXq0pgEzp8fXle_XvAmxSHOAIeYDS5bJdx7LGfwi22JlhIuN1iF7rJunIFGzeuwTvjqwEyBLveDsbjMZmQ3ehi-Ip2e-MzHD6dB-jm_Nf12Z9qdfX74ux0VVlO2VgBE7aTdUuI7TgF0_FO1LZRkhIlgfZtK3uhOOkZsW2rBEBHaSsNVczWyqjlATp51N1M7QCdhVA8eL1JbjBpq6Nx-u1LcGt9G-91zWtWsigCP54EUvw7QR714LIF702AOGVNFWn4kjAlCnr0Dr2LUwrle4VSvAQr61nw-2tHL1aesy8AewRsijkn6LV1o5lDKwad15ToecY6ej3PWM8zLk0_3zU9636I_weGCqlB |
CitedBy_id | crossref_primary_10_1016_j_phymed_2019_152848 crossref_primary_10_1016_j_prp_2023_155038 crossref_primary_10_1080_19490976_2020_1737487 crossref_primary_10_1111_cpr_12776 crossref_primary_10_1007_s12672_022_00467_4 crossref_primary_10_1016_j_yexcr_2019_05_011 crossref_primary_10_1089_dna_2019_4620 crossref_primary_10_1038_s41388_022_02376_w crossref_primary_10_3390_antiox12071327 crossref_primary_10_3389_fendo_2023_1154741 crossref_primary_10_3390_molecules24224100 crossref_primary_10_1007_s10517_025_06343_9 crossref_primary_10_1080_08916934_2018_1477133 crossref_primary_10_1155_2018_7152962 crossref_primary_10_3390_molecules24183393 crossref_primary_10_1134_S1990519X23060111 crossref_primary_10_1158_1535_7163_MCT_19_0168 crossref_primary_10_12677_tcm_2024_1310412 crossref_primary_10_3390_cells10051024 crossref_primary_10_1111_cas_16064 crossref_primary_10_1016_j_resp_2022_103979 crossref_primary_10_1016_j_plefa_2022_102426 crossref_primary_10_1111_cbdd_70014 crossref_primary_10_1186_s12917_024_04429_6 crossref_primary_10_3390_cancers13010143 crossref_primary_10_1007_s12032_024_02422_5 crossref_primary_10_3390_cells14060400 crossref_primary_10_1016_j_ecoenv_2024_117617 crossref_primary_10_1016_j_biopha_2023_115222 crossref_primary_10_3389_fonc_2022_969396 crossref_primary_10_3390_ijms221810172 crossref_primary_10_1002_jcb_29883 crossref_primary_10_2174_1573394717666210705115359 crossref_primary_10_1007_s00335_020_09846_0 crossref_primary_10_3390_ijms22168691 crossref_primary_10_1016_j_yexcr_2021_112779 crossref_primary_10_1038_s41598_024_57852_y crossref_primary_10_18699_SSMJ20230202 crossref_primary_10_1080_13880209_2021_2016866 crossref_primary_10_1016_j_semcancer_2017_10_005 crossref_primary_10_3390_biom10121676 crossref_primary_10_4103_jcrt_jcrt_2225_22 crossref_primary_10_1186_s12957_023_03247_8 crossref_primary_10_1155_2023_3144086 crossref_primary_10_1186_s12885_023_11585_9 crossref_primary_10_1111_1759_7714_15220 crossref_primary_10_1016_j_addr_2021_113918 crossref_primary_10_1016_j_jddst_2023_104375 crossref_primary_10_1038_s41571_021_00564_3 crossref_primary_10_1155_2021_6644018 crossref_primary_10_36106_8014846 crossref_primary_10_1016_j_semcancer_2021_01_003 crossref_primary_10_3389_fpls_2023_1114398 crossref_primary_10_3389_fonc_2024_1428003 crossref_primary_10_3390_ijms25115727 crossref_primary_10_3389_fcimb_2019_00112 crossref_primary_10_1186_s12885_019_5353_6 crossref_primary_10_3390_cancers16061113 crossref_primary_10_1186_s12957_023_02945_7 crossref_primary_10_18036_aubtdc_412520 crossref_primary_10_1007_s10555_021_10017_z crossref_primary_10_1155_2020_2658795 crossref_primary_10_3390_pathogens13111005 crossref_primary_10_3390_cancers15030729 crossref_primary_10_1016_j_semcdb_2021_04_001 crossref_primary_10_1016_j_jss_2024_11_003 crossref_primary_10_1080_14789450_2021_1892491 crossref_primary_10_1007_s00432_021_03644_0 crossref_primary_10_1002_ijc_32624 crossref_primary_10_1038_s41418_023_01149_6 crossref_primary_10_1002_jbt_22553 crossref_primary_10_1002_jev2_12326 crossref_primary_10_2217_fon_2021_1304 crossref_primary_10_3390_ijms242417325 crossref_primary_10_1021_acsami_4c09065 crossref_primary_10_3390_ijms24010252 crossref_primary_10_32604_or_2023_030690 crossref_primary_10_1016_j_amsu_2018_10_024 crossref_primary_10_1186_s12876_023_02870_9 crossref_primary_10_1002_1878_0261_12620 crossref_primary_10_1038_s41467_022_33719_6 crossref_primary_10_1155_2021_5595520 crossref_primary_10_2174_0113816128330427241017110325 crossref_primary_10_1016_j_cyto_2022_156039 crossref_primary_10_1155_2020_7658342 |
Cites_doi | 10.3109/01902140903042589 10.1016/j.jtho.2016.05.021 10.1016/j.lfs.2016.04.023 10.1002/mc.22471 10.1186/s12935-016-0323-4 10.18632/oncotarget.10088 10.1016/j.jtho.2016.05.025 10.18632/oncotarget.10243 10.1093/jb/mvr136 10.1517/14622416.3.6.763 10.18632/oncotarget.6570 10.1016/j.cllc.2016.05.015 10.3390/ijms161226215 10.1186/s13287-015-0179-x 10.1016/j.bcp.2016.06.014 10.3892/or.2016.4897 10.1186/1471-2407-13-496 10.18632/oncotarget.9319 |
ContentType | Journal Article |
Copyright | Copyright Spandidos Publications UK Ltd. 2017 Copyright: © Shang et al. 2017 |
Copyright_xml | – notice: Copyright Spandidos Publications UK Ltd. 2017 – notice: Copyright: © Shang et al. 2017 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. M0S PHGZM PHGZT PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.3892/ol.2017.6048 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection ProQuest One Health & Nursing Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central (New) ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1792-1082 |
EndPage | 4660 |
ExternalDocumentID | PMC5452994 28599466 10_3892_ol_2017_6048 |
Genre | Journal Article |
GeographicLocations | Beijing China United States--US China |
GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
GroupedDBID | --- 0R~ 53G 7X7 8FI 8FJ AAKDD AAYXX ABDBF ABJNI ABUWG ACGFS ACUHS ADBBV AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BENPR BNQBC BPHCQ BVXVI C45 CCPQU CITATION EBD EBS EJD ESX F5P FYUFA H13 HMCUK HUR HZ~ IAO IHR IHW IPNFZ ITC O9- OK1 OVD PHGZM PHGZT PQQKQ PROAC RIG RPM TEORI UKHRP W2D NPM 3V. 7XB 8FK K9. PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c412t-e26cd75b00cd41ead4d65c8971097e1fbb7f6940f20cbb96eed11b7a192c59a93 |
IEDL.DBID | 7X7 |
ISSN | 1792-1074 |
IngestDate | Thu Aug 21 14:34:04 EDT 2025 Thu Jul 10 22:33:41 EDT 2025 Fri Jul 25 08:11:13 EDT 2025 Thu Apr 03 07:08:11 EDT 2025 Tue Jul 01 01:58:28 EDT 2025 Thu Apr 24 23:05:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 6 |
Keywords | lung cancer epithelial-mesenchymal transition tumor necrosis factor-α interleukin-6 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c412t-e26cd75b00cd41ead4d65c8971097e1fbb7f6940f20cbb96eed11b7a192c59a93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5452994 |
PMID | 28599466 |
PQID | 1994946754 |
PQPubID | 2044954 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5452994 proquest_miscellaneous_1908430296 proquest_journals_1994946754 pubmed_primary_28599466 crossref_citationtrail_10_3892_ol_2017_6048 crossref_primary_10_3892_ol_2017_6048 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | Oncology letters |
PublicationTitleAlternate | Oncol Lett |
PublicationYear | 2017 |
Publisher | Spandidos Publications UK Ltd D.A. Spandidos |
Publisher_xml | – name: Spandidos Publications UK Ltd – name: D.A. Spandidos |
References | Chen (key20180108113702_b10-ol-0-0-6048) 2016 Ninsontia (key20180108113702_b9-ol-0-0-6048) 2016; 16 Rhee (key20180108113702_b16-ol-0-0-6048) 2015; 16 Ge (key20180108113702_b12-ol-0-0-6048) 2016; 153 Hsiao (key20180108113702_b11-ol-0-0-6048) 2016; 7 Bo (key20180108113702_b13-ol-0-0-6048) 2013; 13 Cheng (key20180108113702_b1-ol-0-0-6048) 2016; 11 Pore (key20180108113702_b4-ol-0-0-6048) 2016; 17 Rahman (key20180108113702_b6-ol-0-0-6048) 2016; 7 Lee (key20180108113702_b14-ol-0-0-6048) 2016; 7 Shintani (key20180108113702_b5-ol-0-0-6048) 2016; 11 Sarries (key20180108113702_b2-ol-0-0-6048) 2002; 3 Wang (key20180108113702_b17-ol-0-0-6048) 2015; 6 Emmons (key20180108113702_b7-ol-0-0-6048) 2016; 122 Fan (key20180108113702_b8-ol-0-0-6048) 2016; 36 Zhou (key20180108113702_b15-ol-0-0-6048) 2016; 7 Song (key20180108113702_b19-ol-0-0-6048) 2016; 56 Kawata (key20180108113702_b18-ol-0-0-6048) 2012; 151 Yamauchi (key20180108113702_b20-ol-0-0-6048) 2010; 36 Sharma (key20180108113702_b3-ol-0-0-6048) 2015; 11 |
References_xml | – volume: 36 start-page: 12 year: 2010 ident: key20180108113702_b20-ol-0-0-6048 article-title: Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1 publication-title: Exp Lung Res doi: 10.3109/01902140903042589 – volume: 11 start-page: 1653 year: 2016 ident: key20180108113702_b1-ol-0-0-6048 article-title: The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2016.05.021 – year: 2016 ident: key20180108113702_b10-ol-0-0-6048 article-title: miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells publication-title: Oncotarget – volume: 153 start-page: 1 year: 2016 ident: key20180108113702_b12-ol-0-0-6048 article-title: Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways publication-title: Life Sci doi: 10.1016/j.lfs.2016.04.023 – volume: 56 start-page: 36 year: 2016 ident: key20180108113702_b19-ol-0-0-6048 article-title: Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway publication-title: Mol Carcinog doi: 10.1002/mc.22471 – volume: 16 start-page: 48 year: 2016 ident: key20180108113702_b9-ol-0-0-6048 article-title: Zinc induces epithelial to mesenchymal transition in human lung cancer H460 cells via superoxide anion-dependent mechanism publication-title: Cancer Cell Int doi: 10.1186/s12935-016-0323-4 – volume: 7 start-page: 44417 year: 2016 ident: key20180108113702_b11-ol-0-0-6048 article-title: SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.10088 – volume: 11 start-page: 1482 year: 2016 ident: key20180108113702_b5-ol-0-0-6048 article-title: IL-6 secreted from cancer associated fibroblasts mediates chemoresistance in non-small-cell lung cancer by increasing epithelial-mesenchymal transition signaling publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2016.05.025 – volume: 7 start-page: 54852 year: 2016 ident: key20180108113702_b6-ol-0-0-6048 article-title: Lung cancer exosomes as drivers of epithelial mesenchymal transition publication-title: Oncotarget doi: 10.18632/oncotarget.10243 – volume: 151 start-page: 205 year: 2012 ident: key20180108113702_b18-ol-0-0-6048 article-title: TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells publication-title: J Biochem doi: 10.1093/jb/mvr136 – volume: 3 start-page: 763 year: 2002 ident: key20180108113702_b2-ol-0-0-6048 article-title: Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer publication-title: Pharmacogenomics doi: 10.1517/14622416.3.6.763 – volume: 7 start-page: 6626 year: 2016 ident: key20180108113702_b14-ol-0-0-6048 article-title: IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.6570 – volume: 11 start-page: 1033 year: 2015 ident: key20180108113702_b3-ol-0-0-6048 article-title: Lung cancer screening: history, current perspectives, and future directions publication-title: Arch Med Sci – volume: 17 start-page: 535 year: 2016 ident: key20180108113702_b4-ol-0-0-6048 article-title: Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer publication-title: Clin Lung Cancer doi: 10.1016/j.cllc.2016.05.015 – volume: 16 start-page: 30015 year: 2015 ident: key20180108113702_b16-ol-0-0-6048 article-title: Mesenchymal stem cell-mediated effects of tumor support or suppression publication-title: Int J Mol Sci doi: 10.3390/ijms161226215 – volume: 6 start-page: 185 year: 2015 ident: key20180108113702_b17-ol-0-0-6048 article-title: Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells publication-title: Stem Cell Res Ther doi: 10.1186/s13287-015-0179-x – volume: 122 start-page: 1 year: 2016 ident: key20180108113702_b7-ol-0-0-6048 article-title: The role of phenotypic plasticity in the escape of cancer cells from targeted therapy publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2016.06.014 – volume: 36 start-page: 1016 year: 2016 ident: key20180108113702_b8-ol-0-0-6048 article-title: Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1 publication-title: Oncol Rep doi: 10.3892/or.2016.4897 – volume: 13 start-page: 496 year: 2013 ident: key20180108113702_b13-ol-0-0-6048 article-title: Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells publication-title: BMC Cancer doi: 10.1186/1471-2407-13-496 – volume: 7 start-page: 41294 year: 2016 ident: key20180108113702_b15-ol-0-0-6048 article-title: Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition publication-title: Oncotarget doi: 10.18632/oncotarget.9319 |
SSID | ssj0000561886 |
Score | 2.4124806 |
Snippet | The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 4657 |
SubjectTerms | Chemotherapy Cytokines Drug resistance Gene expression Laboratories Lung cancer Medical prognosis Metastasis Oncology Proteins Tumor necrosis factor-TNF Tumors |
Title | IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28599466 https://www.proquest.com/docview/1994946754 https://www.proquest.com/docview/1908430296 https://pubmed.ncbi.nlm.nih.gov/PMC5452994 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB5BKyEuiH9CS2UkOCHTxHHs-IQAdVUQXSHUSnuL4p-0lXaTpZs99LH6IjwTM0k2sCA4x5Ydz9gznvn8DcCrSufOCIq44_2HSyEst4ro8YxOpfE-7UMDJ1N1fCY_z7LZEHBbDbDKzZnYHdS-cRQjPyQOWyoHn8l3y--cqkZRdnUooXEbdom6jCBdeqbHGAt5x3lX7BHVTnDCHvbYd7TS4rChzEOi3-LU8m2r9Jer-Sdi8jcTNLkP9wbfkb3vhf0AboX6Idw5GbLjj6D49IUrVtaenU4n_McNW3ZYu8AWoS3RC1xdrlhTsTnub-ZI2lfMXjO8lK-x_zkLS3qfMUeF5At6k-Qurhc4XEvWrAN2PYazydHpx2M-FFDgTiai5UEo53WGO8t5maDOSK8ylxvCX-qQVNbqShkZVyJ21hqF9jJJrC7R63OZKU36BHbqpg7PgGVxhZ6dVzZzWuZVal2OvlviQ0pl8MoqgjebBSzcwC5ORS7mBd4yaLmLZl7Qche03BG8Hlsve1aNf7Tb38iiGPbWqvilCRG8HD_jrqBUR1mHZk1t4lymsTAqgqe96MaBiLKPWPUj0FtCHRsQ4_b2l_ryomPepoLs2Pf5_6e1B3fpD3pA2T7stFfr8AJdl9YedPp5ALsfjqZfv_0EzrnvXA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB6tuhJwQbwJLGAk9oTMJo7zOiDEY6uWbSuEutLeQvwIW6lNyjYV6p9C4o_wm5hJ0kBBcNuzx3IyHo8_e8bfADzLo1gngm7c8fzDpRCKq5Do8ZLIl4kxfnM1MJ6Eg1P5_iw424Nv27cwlFa59Ym1ozalpjvyI-KwpXLwgXy1_MKpahRFV7clNBqzOLGbr3hkW70cvsP5PRSifzx9O-BtVQGupScqbkWoTRSguWkjPVSkNGGg44SSEiPr5UpFeZhINxeuVioJcRPxPBVlCIV0kGREvoQuf1_6eJTpwf6b48mHj92tDuHxuC4viYYuOGU7Ntn2iAvEUUmxDi96gcqId_fBv8Dtnzmav216_RtwvUWr7HVjXjdhzxa34Mq4jcffhnQ44iHLCsOmkz7_8Z0t6-w-yxa2yhB3rmYrVuZsjh6FabKvC6Y2bFaYNfb_zOySXoTMcQnwBb2C0uebBQ5X0f5Zp5LdgdNLUe5d6BVlYe8DC9wcsaQJVaAjGee-0jGiRc9YnwrvZbkDz7cKTHXLZ05lNeYpnmtI3Wk5T0ndKanbgcNOetnwePxD7mA7F2m7mlfpL9tz4GnXjOuQgitZYcs1ybix9F2RhA7ca6auG4hIAonH34FoZ1I7AeL43m0pZuc11zeVgMe-D_7_WU_g6mA6HqWj4eTkIVyjv2nS2Q6gV12s7SMETpV63Forg0-XvUB-AmdcLO4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRaq4IN4EChiJnpDZjePEyQEhRFl1abvi0Ep7C_Ej7Uq7ydLNCu3P4sqP4DcxkxcsCG4925aT8Yz92f78DcDLXMUmEXTijvsfLoXQXEckj5eoQCbWBs3RwOkkOjqXH6fhdAe-d29hiFbZzYn1RG1LQ2fkA9KwpXTwoRzkLS3i0-Ho7fILpwxSdNPapdNoXOTYbb7i9m31ZnyIY30gxOjD2fsj3mYY4Eb6ouJORMaqEF3PWOmjUaWNQhMnRFBUzs-1VnmUyGEuhkbrJMIFxfe1yhAWmTDJSIgJp_8bKgh9ijE1Vf35DiHzuE40iS4vOPEeG949IgQxKOnWw1ev0Szx9or4F8z9k6352_I3ug23WtzK3jWOdgd2XHEX9k7bm_l7kI5PeMSywrKzyYj_-MaWNc_PsYWrMkSgq9mKlTmb49zCDHnaFdMbNivsGttfMLektyFzDAa-oPdQ5nKzwO4qWklrUtl9OL8W0z6A3aIs3CNg4TBHVGkjHRol4zzQJkbc6FsXUAq-LPfgVWfA1LTK5pRgY57iDofMnZbzlMydkrk9OOhrLxtFj3_U2-_GIm3jepX-8kIPXvTFGJF0zZIVrlxTnWEsg6FIIg8eNkPXd0RygaTo74HaGtS-Aql9b5cUs8ta9ZuSwWPbx___rOewh2GRnownx0_gJv1Mw2vbh93qau2eIoKq9LPaVRl8vu7Y-AkCPS-- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-6+and+TNF-%CE%B1+promote+metastasis+of+lung+cancer+by+inducing+epithelial-mesenchymal+transition&rft.jtitle=Oncology+letters&rft.au=Shang%2C+Guan-Sheng&rft.au=Liu%2C+Lunxu&rft.au=Qin%2C+Yi-Wei&rft.date=2017-06-01&rft.pub=D.A.+Spandidos&rft.issn=1792-1074&rft.eissn=1792-1082&rft.volume=13&rft.issue=6&rft.spage=4657&rft.epage=4660&rft_id=info:doi/10.3892%2Fol.2017.6048&rft_id=info%3Apmid%2F28599466&rft.externalDocID=PMC5452994 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon |